SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

The Lud cold agglutinin: a further antibody recognizing N-acetylneuraminic acid-determined antigens not fully expressed at birth.

D Roelcke
Vox Sanguinis 1981 November
From a patient, a new type of human cold aggluntinin, Lud, which reacts with a determinant involving N-acetylneuraminic acid and which is not fully expressed at birth, is described. This antibody differs from a recently described cold agglutinin, Fl. The antigenic determinant recognized by antibody Lud is diminished after treatment of erythrocytes with proteases, whereas that recognized by Fl is not.

Full text links

Find Full Text Links for this Article

Trending Papers

Management of Latent Tuberculosis Infection.Steven Kim, Rebecca Thal, Daria SzkwarkoJAMA 2023 January 20
The Difficult Airway Redefined.Matthew B Burgess et al.Prehospital and Disaster Medicine 2022 November 10
Misdiagnosis in the Emergency Department: Time for a System Solution.Jonathan A Edlow, Peter J PronovostJAMA 2023 January 28

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app